APA (7th ed.) Citation

Fumery, M., Serrero, M., Bouguen, G., Amiot, A., Altwegg, R., Nachury, M., . . . Buisson, A. (2024). Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent. Journal of Crohn's & Colitis, 18(10), 1615. https://doi.org/10.1093/ecco-jcc/jjae063

Chicago Style (17th ed.) Citation

Fumery, Mathurin, et al. "Real-World Comparison of the Effectiveness Between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at Least One Anti-TNF Agent." Journal of Crohn's & Colitis 18, no. 10 (2024): 1615. https://doi.org/10.1093/ecco-jcc/jjae063.

MLA (9th ed.) Citation

Fumery, Mathurin, et al. "Real-World Comparison of the Effectiveness Between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at Least One Anti-TNF Agent." Journal of Crohn's & Colitis, vol. 18, no. 10, 2024, p. 1615, https://doi.org/10.1093/ecco-jcc/jjae063.